Subscribe
patent-istock-579425600-duncan-andison
Duncan_Andison / iStockphoto.com
17 May 2019Americas

Federal Circuit invalidates Nuvo’s Vimovo patents

The US Court of Appeals for the Federal Circuit has delivered a blow to Nuvo Pharmaceuticals by reversing a decision which had upheld the validity of the Canadian company’s pain relief drug Vimovo (naproxen/esomeprazole magnesium).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Dr Reddy’s found to infringe arthritis drug patent
17 July 2017   A New Jersey judge has ruled today that Dr Reddy’s Laboratories infringed a patent owned by Horizon Pharma.
Americas
Horizon accuses Actavis of infringing Vimovo patents
12 August 2016   Horizon Pharma has filed a complaint against Actavis accusing it of infringing three of patents for the Vimovo (naproxen/esomeprazole magnesium) drug.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
Dr Reddy’s found to infringe arthritis drug patent
17 July 2017   A New Jersey judge has ruled today that Dr Reddy’s Laboratories infringed a patent owned by Horizon Pharma.
Americas
Horizon accuses Actavis of infringing Vimovo patents
12 August 2016   Horizon Pharma has filed a complaint against Actavis accusing it of infringing three of patents for the Vimovo (naproxen/esomeprazole magnesium) drug.

More on this story

Americas
Dr Reddy’s found to infringe arthritis drug patent
17 July 2017   A New Jersey judge has ruled today that Dr Reddy’s Laboratories infringed a patent owned by Horizon Pharma.
Americas
Horizon accuses Actavis of infringing Vimovo patents
12 August 2016   Horizon Pharma has filed a complaint against Actavis accusing it of infringing three of patents for the Vimovo (naproxen/esomeprazole magnesium) drug.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York